Harvard Bioscience Inc (HBIO)
2.72
+0.06
(+2.26%)
USD |
NASDAQ |
Sep 27, 16:00
2.715
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience SG&A Expense (Annual): 46.89M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.89M |
| December 31, 2022 | 49.53M |
| December 31, 2021 | 48.95M |
| December 31, 2020 | 43.42M |
| December 31, 2019 | 46.02M |
| December 31, 2018 | 45.82M |
| December 31, 2017 | 32.61M |
| December 31, 2016 | 41.44M |
| December 31, 2015 | 40.41M |
| December 31, 2014 | 35.05M |
| December 31, 2013 | 37.26M |
| December 31, 2012 | 37.10M |
| December 31, 2011 | 34.70M |
| Date | Value |
|---|---|
| December 31, 2010 | 34.06M |
| December 31, 2009 | 26.87M |
| December 31, 2008 | 26.10M |
| December 31, 2007 | 25.18M |
| December 31, 2006 | 24.55M |
| December 31, 2005 | 20.74M |
| December 31, 2004 | 18.49M |
| December 31, 2003 | 26.78M |
| December 31, 2002 | 18.89M |
| December 31, 2001 | 14.52M |
| December 31, 2000 | 22.78M |
| December 31, 1999 | 9.878M |
| December 31, 1998 | 4.039M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
43.42M
Minimum
2020
49.53M
Maximum
2022
46.96M
Average
46.89M
Median
2023
SG&A Expense (Annual) Benchmarks
| Bruker Corp | 730.10M |
| Azenta Inc | 316.28M |
| Bionano Genomics Inc | 93.50M |
| Akoya Biosciences Inc | 82.38M |
| Singular Genomics Systems Inc | 54.48M |